Longhorn Vaccines & Diagnostics LLC

21 articles about Longhorn Vaccines & Diagnostics LLC

• Longhorn Vaccines and Diagnostics Presents at World Vaccine Congress on Advantages of Single Peptide Vaccine for Broad Coverage of Human and Avian Influenza Viruses

  4/2/2024

  Longhorn Vaccines and Diagnostics Congress all day April 2-4, 2024 on a mice study that examined LHNVD-110, a novel, unconjugated single peptide vaccine comprised of multiple epitopes to broadly target human and influenza viruses.

• Longhorn Vaccines and Diagnostics Presents Targeted Vaccine Approach for Mycobacterium Tuberculosis with LHNVD-301

  11/15/2023

  Longhorn Vaccines and Diagnostics today presented new data from an animal study of LHNVD-301, the company’s lead tuberculosis vaccine candidate.

• Longhorn Vaccines and Diagnostics to Present Data on Mycobacterium Tuberculosis Vaccine Candidate, LHNVD-301, at The Union World Conference on Lung Health 2023

  11/2/2023

  Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, will present new data from an animal study of LHNVD-301, the company’s tuberculosis vaccine candidate, at The Union World Conference on Lung Health 2023.

• Longhorn Vaccines and Diagnostics Announces Data Showing PrimeStore® Molecular Transport Medium Inactivates High Consequence Animal Viruses

  10/12/2023

  Longhorn Vaccines and Diagnostics announced today new data from the USDA National Veterinary Services Laboratory validating the company’s core diagnostic product, PrimeStore® Molecular Transport Medium (PS-MTM), and its potential to inactivate highly consequential livestock and poultry viruses to support safer and more effective diagnostic testing.

• Longhorn Vaccines and Diagnostics Presents Data Demonstrating Neutralizing Activity of LHNVD-201 for Covid-19 and Influenza Co-Infections

  9/25/2023

  Longhorn Vaccines and Diagnostics today presented new data from an animal study showing that LHNVD-201, the company’s unconjugated peptide vaccine candidate, generated broad and durable neutralizing antibodies against Covid-19 and influenza viruses. Study results were presented at the 17th Vaccine Congress, taking place in Glasgow, Scotland from September 24-27, 2023.

• Longhorn Vaccines and Diagnostics to Present Durability Data of Peptide-Based Vaccine LHNVD-201 for Covid-19 and Influenza Co-Infections at 17th Vaccine Congress

  9/19/2023

  Longhorn Vaccines and Diagnostics to Present Durability Data of Peptide-Based Vaccine LHNVD-201 for Covid-19 and Influenza Co-Infections at 17th Vaccine Congress.

• Longhorn Vaccines and Diagnostics Reports Composite Peptide Vaccines Generate Immune Responses to Both Influenza and Coronavirus

  10/24/2022

  Longhorn Vaccines and Diagnostics LLC reported data today from a pre-clinical study of an adjuvanted composite peptide vaccine comprised of various conserved epitopes from both influenza and coronavirus.

• Longhorn Vaccines and Diagnostics to Present at Infectious Disease Week 2022

  10/19/2022

  Longhorn Vaccines and Diagnostics LLC today announced that it will present two abstracts at Infectious Disease (ID) Week, being in Washington, DC, Oct. 19 – 23, 2022.

• Longhorn Vaccines and Diagnostics to Present at The Allen D. Leman Swine Conference

  9/19/2022

  Longhorn Vaccines and Diagnostics LLC , a One Health and One World company developing vaccines and diagnostic tools for global public health and zoonosis concerns, today announced that Jerry Torrison, DVM, PhD, Senior Vice President of Animal Health, will present at the Allen D. Leman Swine Conference, being held in the St. Paul River Center, Minnesota, on Sept. 17 – 20, 2022.

• 

  Movers & Shakers: Homology Medicines, GlycoMimetics, MiMedx and More Tap New Execs

  9/9/2022

  Homology Medicines and MiMedx both posted new CEOs. Other C-suite positions, including CFOs and CMOs were also filled this week.

• Longhorn Vaccines and Diagnostics Appoints Zoe Silver as Senior Vice President of Genomics & Diagnostics

  9/8/2022

  Longhorn Vaccines and Diagnostics LLC, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, announced that Zoe Silver has joined the company as Senior Vice President of Genomics & Diagnostics.

• Longhorn Vaccines & Diagnostics and SiO2 Materials Science Team Up to Develop 12 Millimeter Sample Transport Media for Higher Volumes of Automated Virus Testing

  10/4/2021

  Longhorn Vaccines & Diagnostics today announced a partnership to produce and distribute PrimeStore® MTM in SiO2’s proprietary 12 millimeter sample transport tubes.

• Longhorn’s Universal Influenza Vaccine Candidate LHNVD-105 Shows Promising Strain Coverage

  7/20/2021

  Longhorn Vaccines & Diagnostics, LLC, a privately held biotechnology company, announced publication of pre-clinical data on the company’s universal influenza vaccine candidate, LHNVD-105, which is a multi-epitope unconjugated influenza composite peptide formulated in collaboration with the U.S. Army’s Liposomal Adjuvant.

• Longhorn Vaccines & Diagnostics to Present at 2021 BIO Digital

  6/10/2021

  Longhorn Vaccines & Diagnostics announced today that it has been selected to deliver a presentation on the past success and future opportunities for its lead product, PrimeStore MTM.

• Longhorn Vaccines and Diagnostics LLC, and Greenfield Global Inc. partner to accelerate COVID-19 Testing and Detection

  6/15/2020

   Longhorn Vaccines & Diagnostics, an innovative molecular tool, assay and vaccine development company, and Pharmco, Greenfield Global's popular brand of specialty al

• Longhorn Vaccines & Diagnostics and Cenetron Diagnostics Team up with Coca-Cola Bottlers to Produce COVID-19 Test Kits

  6/1/2020

  Longhorn Vaccines & Diagnostics , an innovative molecular tool, assay and vaccine development company focused on serving unmet critical needs in both developed and developing nations, and Cenetron Diagnostics , a cutting-edge clinical research logistics management company, today announced a collaboration with Southeastern Container (SEC), to expand production of COVID-19 testing kits. SEC is a co-o

• Longhorn Vaccines & Diagnostics to Present at The 50th Union World Conference on Lung Health

  10/23/2019

  The conference is the largest gathering of clinicians and public health workers, health program managers, policymakers, researchers and advocates working to end the suffering caused by lung disease with a focus specifically on the challenges faced by low-and lower-middle income populations.

• Longhorn Vaccines & Diagnostics LLC Release: PrimeStore Molecular Transport Medium Aiding Laboratories Tracking H7N9 Avian Influenza

  3/23/2017

• Longhorn Vaccines & Diagnostics LLC Announces PrimeStore Molecular Transport Medium Significantly Improves Cepheid Xpert MTB/RIF Sensitivity In Crucial Low Copy Samples

  7/18/2016

• Longhorn Vaccines & Diagnostics LLC's PrimeSuite TB Products Included In The 2015 UNITAID Tuberculosis Diagnostics Technology And Market Landscape

  11/2/2015